- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02337075
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities in Indigenous Communities (PATH)
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities Using Digital Technology in Indigenous Communities
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Background: Promoting an active lifestyle is a priority identified by the communities served by KDC Health. Statistics Canada estimates obesity in one in four adults based on 2007-2009 data, with higher prevalence among Indigenous people compared to non-Aboriginal population (between 26% and 36% among adults living off-reserve and on-reserve, respectively). Furthermore, Indigenous people also report higher prevalence of obesity associated complications, including diabetes, cardiovascular disease, and arthritis. The association between physical inactivity and obesity suggests that increasing physical activity is important.
KDC Health offers a variety of free programs to community members, however, the use of these services has been low. KDC Health has previously partnered with the CIHR-funded IMPAKT project, and has expressed a strong interest in developing an intervention to improve health and wellness in the communities.
Objectives:
- To determine whether the PATH program can improve physical activity participation in the communities served by KDC Health.
- To assess the effect of this program on reducing sedentary time, and increasing the use of health promotion and wellness services offered by KDC Health
- To assess the correlation of physical activity levels and the secondary outcome measures among individuals who are living in the same household.
Methods: The investigators will conduct a community-based proof-of-concept randomized controlled trial (RCT) with 60 eligible participants. Only 1 member per household will be enrolled. If more than 1 member is interested, they will select 1 person by consensus or by a random draw.
After obtaining the baseline measures, participants will be randomly assigned to the 'Now Group' (target=30) or 'Later Group' (target=30).
The Now Group will participate in a brief education session held at the KDC Health Centre, use a wearable physical activity tracker (Fitbit Flex), and physical activity mentoring by a KDC Health Staff (the Activity Mentors). The Activity Mentors have received training for the project from the Principal Investigator. In Month 1-2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre. In Month 3-4, they will continue to use Fitbit Flex but will no longer have regular meetings with the Activity Mentor.
The Later Group will receive intervention two months later (i.e., Month 3-4).
The primary outcome measure will be the time spent in moderate/vigorous physical activity. In addition, time spent in sedentary behaviours will be recorded. Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, 2 months, and 4 months. Secondary outcome measures include sedentary time measured with SenseWear Mini, health status that will be measured using the SF-36 (a generic measure of health-related quality of life), and body weight. Participants' use of KDC Health programs and their motivation to be physically active will also be recorded.
At the end of the program, participants will be interviewed for 30 minutes in person about their opinion on the intervention. Interviews will focus on 1) barriers/facilitators to being physically active, 2) their experience with the intervention, and 3) the nature of activities they engage in.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
British Columbia
-
Richmond, British Columbia, Canada, V6X 2C7
- Arthritis Research Canada
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria: Participants are eligible if they:
- Are a person from KDC Health Member Nations
- Are 19 years or older
- Have no health condition that prevents them from being physically active
- Are able to participate in a 4-month project -
Exclusion Criteria: Participants are not eligible to participate if they:
- Do not meet the criteria above
- Use medication that may impair activity tolerance (e.g., beta blockers),
- Are unable to provide informed consent -
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Now Group - PATH Program
The Now Group will receive the PATH program.
They will participate in a brief education session, use a wearable physical activity tracker, and physical activity mentoring by an Activity Mentors.
In Month 1 and 2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre.
In Month 3 and 4, they will continue to use physical activity tracker but will no longer have regular meetings with the Activity Mentor.
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
Comparateur actif: Later Group
The Later Group will receive the PATH program in Month 1-2.
Intervention will be provided two months later (i.e., Month 3 and 4).
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Time spent in Moderate to Vigorous Physical Activity (MVPA), measured by SenseWear Mini accelerometer
Délai: Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Time spent in sedentary behaviours, measured by SenseWear Mini accelerometer
Délai: Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
Change in Health Status, measured by SF-36 Questionnaire
Délai: Change from baseline health status at 2 months and 4 months
|
SF-36 Questionnaire
|
Change from baseline health status at 2 months and 4 months
|
Change in Body weight, measured by measured with a calibrated scale
Délai: Change from baseline body weight at 2 months and 4 months
|
Measured with a calibrated scale
|
Change from baseline body weight at 2 months and 4 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Linda Li, PT, PhD, Arthritis Research Canada
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- H12-02526
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur En bonne santé
-
AstraZenecaParexelComplété
Essais cliniques sur PATH program
-
Weill Medical College of Cornell UniversityCornell UniversityPas encore de recrutementFardeau des soignantsÉtats-Unis
-
Perception Dynamics InstituteUniversity of California, San Diego; University of South AlabamaRetiréDéclin cognitif lié à l'âgeÉtats-Unis
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)Complété
-
Michael StewartNova Scotia Health AuthorityRecrutementSyndrome de l'intestin irritable | Troubles gastro-intestinauxCanada
-
Abbott Medical DevicesComplétéFlutter auriculaire typiqueÉtats-Unis, Canada
-
Akdeniz UniversityPas encore de recrutementAVC ischémique | EncadrementTurquie
-
PATHComplétéInjections intradermiquesÉtats-Unis
-
St Elizabeth HealthcarePATH Decision Support Software, LLCComplétéDiabète sucréÉtats-Unis
-
Johns Hopkins UniversityThe Rita and Alex Hillman Foundation; Abell Foundation; Richman Foundation; Sherman... et autres collaborateursRecrutementParentalité | Intervention parentaleÉtats-Unis
-
University of Texas Rio Grande ValleyHealth and Human Services Commission (HHSC); Pharr-San Juan-Alamo Independent... et autres collaborateursActif, ne recrute pasComportement lié à la santéÉtats-Unis